Mithra rises as it appoints new CEO

Mithra Pharmaceuticals SA

04/04/2023 08:33

** Shares of Mithra Pharmaceuticals   MITRA.BR  rise 6.4%
after the Belgian biotech group appoints David H. Solomon as its
new CEO, effective April 11
    ** Solomon is a medical doctor with over 30 years of
experience in operations innovation, strategic business
development and dealmaking in the biopharma industry, Mithra
says
    ** "Dr. Solomon has an impressive tenure with CEO roles at
multiple listed biotech companies, and could be the right fit to
continue at the helm of the Mithra story," KBC Securities says
in a note
    ** The broker adds Solomon comes in at a critical time, "as
the company stands before a potential commercial U.S. deal for
Donesta ... and seeks to optimize the potential of its CDMO
facilities"
    ** ING, however, says it prefers to "investigate first" as
"the structures in which he (Solomon) worked are relatively
small"
        ** Including Tuesday's rise, the stock is down 14.5% YTD
    

 (Reporting by Dina Kartit)
 ((dina.kartit@thomsonreuters.com))